Growth at Reasonable Price

Results

160

33 new

160 companies

CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv YieldIndustry
MDGL
US$537.65-2.3%75.3%US$12.6bUS$679.6410.959.7%n/aPharmaceuticals & Biotech
NVDA
US$212.062.2%22.1%US$5.1tUS$302.8332.222.8%0.5%Semiconductors
INR
US$13.615.8%-3.4%US$852.6mUS$22.635.949.0%n/aEnergy
SNDX
US$22.05-6.3%115.8%US$2.0bUS$39.459.068.1%n/aPharmaceuticals & Biotech
PICS
US$12.365.6%n/aUS$1.6bUS$20.396.922.8%n/aDiversified Financials
AVGO
US$396.810.6%39.9%US$1.8tUS$525.4464.433.5%0.7%Semiconductors
APP
US$412.48-8.9%13.9%US$144.0bUS$654.6035.421.7%n/aSoftware
ANAB
US$52.61-5.8%94.9%US$1.6bUS$87.096.748.1%42.8%Pharmaceuticals & Biotech
SMCI
US$30.5613.6%-40.9%US$16.5bUS$38.0715.825.4%n/aTech
ARDX
US$5.08-4.2%15.7%US$1.3bUS$16.302.956.0%n/aPharmaceuticals & Biotech
FPS
US$38.87-8.8%n/aUS$12.3bUS$59.90556.043.4%n/aCapital Goods
IONS
US$54.01-1.3%27.4%US$8.8bUS$92.008.461.0%n/aPharmaceuticals & Biotech
WBI
New
US$36.214.9%n/aUS$4.4bUS$34.432.777.2%0.6%Energy
ALHC
US$20.77-0.8%67.5%US$4.4bUS$24.92216.839.5%n/aHealthcare
ORCL
US$125.84-5.0%-48.0%US$366.0bUS$248.1521.324.2%1.6%Software
EROC
US$12.322.2%n/aUS$3.6bUS$22.633.156.3%n/aCapital Goods
TYGO
US$1.800.6%37.4%US$133.6mUS$6.8540.543.3%n/aCapital Goods
AGBK
US$6.79-4.1%n/aUS$1.1bUS$13.981.228.7%n/aBanks
FLEX
New
US$127.00-1.3%136.1%US$46.7bUS$170.7052.937.8%n/aTech
PTHS
US$26.47-2.7%21.0%US$93.4mUS$57.713.365.9%n/aPharmaceuticals & Biotech
ALKT
New
US$16.48-7.0%-41.3%US$1.9bUS$21.713.7106.0%n/aSoftware
COMP
US$11.26-11.0%55.3%US$8.5bUS$13.92580.235.8%n/aReal Estate Management and Development
RCEL
US$4.944.4%-21.1%US$156.7mUS$9.072.164.1%n/aPharmaceuticals & Biotech
BMRC
US$28.460.2%15.9%US$461.3mUS$29.201.2109.0%3.5%Banks
Page 1 of 5